Email Alert | RSS    帮助

中国防痨杂志 ›› 2020, Vol. 42 ›› Issue (2): 95-100.doi: 10.3969/j.issn.1000-6621.2020.02.004

• 论著 • 上一篇    下一篇

中西医结合治疗耐多药肺结核的系统评价/Meta分析的再评价

马改霞,田黎明,王钰,邱磊,薛玲娜,鹿振辉,张惠勇,郭晓燕()   

  1. 200032 上海中医药大学附属龙华医院呼吸疾病研究所
  • 收稿日期:2019-12-26 出版日期:2020-02-10 发布日期:2020-02-19
  • 通信作者: 郭晓燕 E-mail:gxy80@126.com
  • 基金资助:
    “十三五”国家科技重大专项(2018ZX10725-509)

Systematic evaluation and meta-analysis of integrated traditional Chinese and western medicine in the treatment of MDR-PTB

MA Gai-xia,TIAN Li-ming,WANG Yu,QIU Lei,XUE Ling-na,LU Zhen-hui,ZHANG Hui-yong,GUO Xiao-yan()   

  1. Institute of Respiratory Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
  • Received:2019-12-26 Online:2020-02-10 Published:2020-02-19
  • Contact: Xiao-yan GUO E-mail:gxy80@126.com

摘要:

目的 对中西医结合治疗耐多药肺结核的系统评价/Meta分析的文献方法学质量和报告质量进行再评价研究。 方法 通过计算机检索PubMed、EMbase、Cochrane Library、CBM、万方、CNKI和VIP数据库,收集中西医结合治疗耐多药肺结核的系统评价/Meta分析文献,检索时限均从建库至2019年8月。采取主题词和自由词相结合的方式,初步筛选出30篇文献,排除重复发表的15篇文献和非耐多药肺结核的10篇文献,最终纳入5篇文献进行研究。采用AMSTAR量表和GRADE分级评价系统对纳入文献进行方法学质量和报告质量评价。 结果 共纳入5篇系统评价/Meta分析文献,获得8个结局指标,分别为痰菌阴转率、肺部病灶吸收率、空洞闭合率、不良反应发生率、中医证候改善率、治愈率、复发率、治疗有效率。纳入文献均采用中药联合西药与单纯西药治疗进行比较。AMSTAR量表评分显示,3篇分值为6分,属于中等质量;1篇分值为7分,1篇分值为9分,属于高质量。GRADE分级显示,5篇文献的8个结局指标中有1篇痰菌阴转率结局指标证据质量为极低级,其余17个指标为中级(3个)或低级(14个)。5篇文献描述分析结果显示,中西医结合治疗耐多药肺结核,可提高强化期和巩固期的痰菌阴转率及肺部病灶吸收率,改善患者临床症状,提高空洞闭合率,不良反应率相对较低。 结论 中西医结合治疗耐多药肺结核具有协同增效的作用,其系统评价/Meta分析的方法学质量为中高级,但结论的证据强度较低,需加强系统评价的方法学质量和报告质量。

关键词: 医学,中国传统, 结核,抗多种药物性, Meta分析, 评价研究

Abstract:

Objective To reevaluate the qualities of literature methodology and report on systematic evaluation/meta-analysis of integrated traditional Chinese and western medicine in the treatment of multidrug-resistant pulmonary tuberculosis (MDR-TB). Methods The databases, including PubMed, EMbase, Cochrane Library, CBM, WanFang, CNKI and VIP databases, were searched by computer to collect systematic evaluation/meta-analysis literatures on the treatment of MDR-TB by integrated traditional Chinese and western medicine. The retrieval time was from the establishment of the database to August 2019. Based on the combination of subject words and free words, 30 literatures were initially screened out, and then 15 repeatedly published literatures and 10 literatures of non-MDR-TB were excluded, finally, 5 literatures were included for research. The methodological quality and report quality of the included literature were evaluated using AMSTAR scale and GRADE classification evaluation system. Results A total of 5 systematic evaluation/meta-analysis literatures were included, and 8 outcome indicators were obtained, including sputum negative conversion rate, lung lesion absorption rate, cavity closure rate, adverse reaction rate, improvement of traditional Chinese medicine (TCM) syndromes, cure rate, and relapse rate and treatment effective rate. All the included literatures compared the western medicine combined with TCM and western medicine alone. According to the AMSTAR scale score, the three literatures were 6 scores with the medium quality; as well as one literature was 7 scores and one was 9 scores with the high quality. GRADE classification showed that among the eight outcome indicators of 5 literatures, sputum negative conversion rate in 1 literature was very low quality, and the remaining 17 indicators were intermediate (3) or low (14) quality. The results of descriptive analysis showed that the combined treatment of traditional Chinese and western medicine for MDR-TB could elevate the sputum negative conversion rate and lung lesion absorption rate at the strengthening and consolidation stages, and improve the clinical symptoms of patients, meanwhile, the cavity closure rate and adverse reaction rate were relatively lower. Conclusion Integrated traditional Chinese and western medicine in the treatment of MDR-TB has synergistic effect, and the methodological quality of systematic evaluation/meta-analysis is medium and advanced, but the evidence strength of conclusion is low. Thus, the methodological quality and report quality of systematic evaluation should be strengthened.

Key words: Medicine,Chinese traditional, Tuberculosis,multidrug-resistant, Meta-analysis, Evaluation studies